BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16832154)

  • 1. Beneficial effect of cilnidipine on morning hypertension and white-coat effect in patients with essential hypertension.
    Yamagishi T
    Hypertens Res; 2006 May; 29(5):339-44. PubMed ID: 16832154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
    Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
    J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of white coat effect by cilnidipine in essential hypertension.
    Morimoto S; Takeda K; Oguni A; Kido H; Harada S; Moriguchi J; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Am J Hypertens; 2001 Oct; 14(10):1053-7. PubMed ID: 11710785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bedtime administration of cilnidipine controls morning hypertension.
    Ashizawa N; Seto S; Shibata Y; Yano K
    Int Heart J; 2007 Sep; 48(5):597-603. PubMed ID: 17998769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine.
    Tominaga M; Ohya Y; Tsukashima A; Kobayashi K; Takata Y; Koga T; Yamashita Y; Fujishima Y; Abe I; Fujishima M
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):43-8. PubMed ID: 9140677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.
    Ito T; Fujimoto N; Ishikawa E; Dohi K; Fujimoto M; Murata T; Kiyohara M; Takeuchi H; Koyabu S; Nishimura H; Takeuchi T; Ito M
    Clin Exp Hypertens; 2019; 41(1):92-99. PubMed ID: 29584458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of sustained blood pressure-lowering effect of azelnidipine guided by self-measured morning and evening home blood pressure: subgroup analysis of the At-HOME study.
    Kario K; Uehara Y; Shirayama M; Takahashi M; Shiosakai K; Hiramatsu K; Komiya M; Shimada K
    Drugs R D; 2013 Mar; 13(1):75-85. PubMed ID: 23519655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of azelnidipine tablets on morning hypertension.
    Kario K; Sato Y; Shirayama M; Takahashi M; Shiosakai K; Hiramatsu K; Komiya M; Shimada K
    Drugs R D; 2013 Mar; 13(1):63-73. PubMed ID: 23512719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a novel calcium channel blocker on abnormal nocturnal blood pressure in hypertensive patients.
    Kario K; Nariyama J; Kido H; Ando S; Takiuchi S; Eguchi K; Niijima Y; Ando T; Noda M
    J Clin Hypertens (Greenwich); 2013 Jul; 15(7):465-72. PubMed ID: 23815534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning rise of blood pressure assessed by home blood pressure monitoring is associated with left ventricular hypertrophy in hypertensive patients receiving long-term antihypertensive medication.
    Shibuya Y; Ikeda T; Gomi T
    Hypertens Res; 2007 Oct; 30(10):903-11. PubMed ID: 18049021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive therapy for refractory morning hypertension in patients on peritoneal dialysis].
    Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
    Nihon Jinzo Gakkai Shi; 2005; 47(1):38-45. PubMed ID: 15754762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study.
    Obara T; Ohkubo T; Kikuya M; Asayama K; Metoki H; Inoue R; Oikawa T; Komai R; Murai K; Horikawa T; Hashimoto J; Totsune K; Imai Y;
    Blood Press Monit; 2005 Dec; 10(6):311-6. PubMed ID: 16496446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of valsartan plus either cilnidipine or hydrochlorothiazide on home morning blood pressure surge evaluated by information and communication technology-based nocturnal home blood pressure monitoring.
    Fujiwara T; Tomitani N; Kanegae H; Kario K
    J Clin Hypertens (Greenwich); 2018 Jan; 20(1):159-167. PubMed ID: 29316213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
    Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
    Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
    Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
    Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
    Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
    Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
    Soeki T; Kitani M; Kusunose K; Yagi S; Taketani Y; Koshiba K; Wakatsuki T; Orino S; Kawano K; Sata M
    Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
    Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
    Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy.
    Kuriyama S; Otsuka Y; Iida R; Matsumoto K; Tokudome G; Hosoya T
    Intern Med; 2005 Dec; 44(12):1239-46. PubMed ID: 16415543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.